EX-2.1
from 8-K
24 pages
Agreement and Plan of Merger Among: Innovate Biopharmaceuticals, Inc. a Delaware Corporation; Naia Merger Sub, Inc. a Delaware Corporation; Second Naia Merger Sub, LLC a Delaware Limited Liability Company; Naia Rare Diseases, Inc. an Exempted Company Incorporated Under the Laws of the Cayman Islands; and Naia Limited an Exempted Company Incorporated Under the Laws of the Cayman Islands, as Shareholders’ Agent Dated as of April 30, 2020
12/34/56
EX-2.1
from 8-K
137 pages
Agreement and Plan of Merger and Reorganization Among: Innovate Biopharmaceuticals, Inc., INNT Merger Sub 1 Ltd., Rdd Pharma Ltd. Orbimed Israel Partners, Limited Partnership, as the Shareholder Representative Dated as of October 6, 2019
12/34/56